IMSI-Strict is for non-clinical research use only.

See us at ESHRE 2012 for the latest information on Commercial Release

Strict Citeria Brought to IMSI

	Image courtesy of Dr. J. Pfeffer, Dr. J. P. Taar, Dr S. Zerah, Mr. G. Moyer, and Me. M. Louison Cinique de la DHUYS, Centre d'AMP 1-9 rue Pierre et Marie Curie Laboratoire ZTP, BAGNOLET FRANCE
	Image courtesy of Pr Jean Parinaud, MD, PhD, Dr Roger Leandri, MD, PhD, Mr Gérard Vieitez, MSc, Dr Nicolas Gatimel Centre d'Assistance Médicale à la Procréation Hôpital Paule de Viguier, Hôpitaux de Toulouse 330 avenue de Grande Bretagne 31059 TOULOUSE Cedex 9, FRANCE

Combines motile sperm organelle morphology examination (MSOME) and Tygerberg Strict Criteria

Real-time, automated computer analysis of live sperm morphology under high magnification

Choice of 63x dry or 100x oil evaluation

Software solution that can be installed on any Windows-compatible IMSI workstation with Nomarski (DIC)

Research confirms that IMSI improves outcomes for ICSI patients.

“The pooled data of IMSI cycles demonstrate a statistically significant improvement in implantation and pregnancy rates and a statistically significant reduction in miscarriage rates.”

Souza Setti A, Ferreira RC, Paes de Almeida Ferreira Braga D, de Cássia Sávio Figueira R, Iaconelli A Jr, Borges E Jr. Intracytoplasmic sperm injection outcome versus intracytoplasmic morphologically selected sperm injection outcome: a meta-analysis. Reprod Biomed Online. 2010 Oct;21(4):450-5. Epub 2010 Jun 19. Review. PubMed PMID: 20800549.

Intracytoplasmic morphologically selected sperm injection benefits for patients with oligoasthenozoospermia according to the 2010 World Health Organization reference values.

The comparison between the outcomes of intracytoplasmic morphologically selected sperm injection performed in
couples with male factor infertility according to the World Health Organization guidelines from 1999 and 2010 was
the objective of this study. Our results suggest that the sperm selection under high magnification results in improved
treatment outcomes in patients with oligoasthenoterato-zoospermia, according to the new World Health Organization
guidelines. (Fertil Steril 2011;95:2711–4. 2011 by American Society for Reproductive Medicine.)

Intracytoplasmic morphologically selected sperm injection benefits for patients with oligoasthenozoospermia according to the 2010 World Health Organization reference values.

Images captured on Leica AM6000 (www.leicamicrosystems.com)

Return to Top